substance p has been researched along with Adenomatosis, Familial Endocrine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badet, C; Carreau, A; Chayvialle, JA; Laville, M; Mornex, R; Riou, JP; Rousset, H | 1 |
| Eckhauser, FE; Strodel, WE; Thompson, NW; Vinik, AI | 1 |
2 other study(ies) available for substance p and Adenomatosis, Familial Endocrine
| Article | Year |
|---|---|
[Multiple endocrine neoplasia type 1. Digestive hormones in the screening].
Topics: Adolescent; Adult; Aged; Blood Glucose; C-Peptide; Child; Female; Gastrins; Glucagon; Humans; Insulin; Male; Middle Aged; Multiple Endocrine Neoplasia; Pancreatic Neoplasms; Pancreatic Polypeptide; Pituitary Neoplasms; Risk Factors; Substance P; Ultrasonography; Vasoactive Intestinal Peptide | 1993 |
Hyperparathyroidism and gastroenteropancreatic hormone levels.
Topics: Adult; Aged; Female; Gastrins; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptides; Humans; Hyperparathyroidism; Male; Middle Aged; Motilin; Multiple Endocrine Neoplasia; Pancreatic Hormones; Pancreatic Polypeptide; Parathyroid Glands; Somatostatin; Substance P; Vasoactive Intestinal Peptide | 1985 |